ATE464899T1 - Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien - Google Patents
Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterienInfo
- Publication number
- ATE464899T1 ATE464899T1 AT07731175T AT07731175T ATE464899T1 AT E464899 T1 ATE464899 T1 AT E464899T1 AT 07731175 T AT07731175 T AT 07731175T AT 07731175 T AT07731175 T AT 07731175T AT E464899 T1 ATE464899 T1 AT E464899T1
- Authority
- AT
- Austria
- Prior art keywords
- canthin
- mycobacteria
- analogues
- treatment
- diseases caused
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0602677A FR2899229B1 (fr) | 2006-03-28 | 2006-03-28 | Utilisation de la canthin-6-one et ses analogues dans le traitement des pathologies liees aux micobacteries |
| PCT/FR2007/000486 WO2007110500A1 (fr) | 2006-03-28 | 2007-03-22 | Utilisation de la canthin-6-one et ses analogues dans le traitement des pathologies liees aux mycobacteries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE464899T1 true ATE464899T1 (de) | 2010-05-15 |
Family
ID=36979514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07731175T ATE464899T1 (de) | 2006-03-28 | 2007-03-22 | Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110059977A1 (de) |
| EP (1) | EP1998770B1 (de) |
| CN (1) | CN101448499B (de) |
| AP (1) | AP2721A (de) |
| AT (1) | ATE464899T1 (de) |
| BR (1) | BRPI0709673A2 (de) |
| DE (1) | DE602007005992D1 (de) |
| FR (1) | FR2899229B1 (de) |
| WO (1) | WO2007110500A1 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES503557A0 (es) * | 1980-07-03 | 1982-04-01 | Omnichem Sa | Procedimiento de preparacion de alquil-3 tetrahidro-1,2,3, 3a-4h-indolo(3,2,1-de)-1,5-naftiridinas. |
| CN1551761A (zh) * | 2001-04-06 | 2004-12-01 | ���ݴ�ѧУ��ίԱ�� | 酰基氨基葡萄糖环己六醇酰胺酶抑制剂及其使用方法 |
| FR2847474B1 (fr) * | 2002-11-25 | 2006-03-24 | Inst Rech Developpement Ird | Utilisation de la canthin-6-one, des extraits de plantes la contenant et de ses derives dans le traitement de la maladie de chagas |
-
2006
- 2006-03-28 FR FR0602677A patent/FR2899229B1/fr not_active Expired - Fee Related
-
2007
- 2007-03-22 CN CN2007800183867A patent/CN101448499B/zh not_active Expired - Fee Related
- 2007-03-22 BR BRPI0709673-9A patent/BRPI0709673A2/pt not_active IP Right Cessation
- 2007-03-22 EP EP07731175A patent/EP1998770B1/de not_active Not-in-force
- 2007-03-22 AP AP2008004644A patent/AP2721A/xx active
- 2007-03-22 WO PCT/FR2007/000486 patent/WO2007110500A1/fr active Application Filing
- 2007-03-22 US US12/294,668 patent/US20110059977A1/en not_active Abandoned
- 2007-03-22 DE DE602007005992T patent/DE602007005992D1/de active Active
- 2007-03-22 AT AT07731175T patent/ATE464899T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1998770A1 (de) | 2008-12-10 |
| CN101448499B (zh) | 2012-09-05 |
| AP2008004644A0 (en) | 2008-10-31 |
| EP1998770B1 (de) | 2010-04-21 |
| BRPI0709673A2 (pt) | 2011-07-19 |
| FR2899229B1 (fr) | 2008-05-30 |
| CN101448499A (zh) | 2009-06-03 |
| DE602007005992D1 (de) | 2010-06-02 |
| US20110059977A1 (en) | 2011-03-10 |
| FR2899229A1 (fr) | 2007-10-05 |
| WO2007110500A8 (fr) | 2008-12-11 |
| AP2721A (en) | 2013-08-31 |
| WO2007110500A1 (fr) | 2007-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE519488T1 (de) | Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten | |
| ATE448206T1 (de) | Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen | |
| DE602005022427D1 (de) | Verwendung von flibanserin bei der behandlung von prämenstruellen störungen | |
| DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| ATE524479T1 (de) | Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren | |
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| DE602006018583D1 (de) | Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten | |
| CR10699A (es) | Antagonistas de wnt y su uso en el diagnostico y tratamiento de trastornos mediados por wnt | |
| DE602005026984D1 (de) | Chinolin-derivate zur behandlung von latenter tuberkulose | |
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| ATE499105T1 (de) | Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen | |
| ITMI20050262A1 (it) | Sostanze composizioni e metodi di trattamento dell'alopecia | |
| ATE495179T1 (de) | Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen | |
| DE602006006354D1 (de) | Pinolensäure zur Behandlung von Übergewicht | |
| DE50306850D1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
| ATE524183T1 (de) | Verwendung von sanglifehrin bei der hcv-therapie | |
| ATE489091T1 (de) | Dha-ester und ihre verwendung bei der behandlung und der prävention von kardiovaskulären erkrankungen | |
| CL2007003038A1 (es) | Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos. | |
| ATE483460T1 (de) | Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut | |
| ATE542804T1 (de) | 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen | |
| DE602006007323D1 (de) | VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| ATE449769T1 (de) | 3-(4-ää4-(4ää3-(3,3-dimethyl-1- piperidinyl)propyläoxyüphinylü-1- piperidinylcarbonylü-1-naphthalinyl)propan- oder propensäure als h1- und h3-rezeptor-antagonisten zur behandlung entzündlicher und/oder allergischer erkrankungen | |
| ATE518531T1 (de) | Alpha-humulene zur verwendung bei der prophylaxe oder behandlung der entzündlichen schmerzen und des ödems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |